{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33558710",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "02",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "02",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41416-021-01276-2"
    ],
    "Journal": {
      "ISSN": "1532-1827",
      "JournalIssue": {
        "Volume": "124",
        "Issue": "7",
        "PubDate": {
          "Year": "2021",
          "Month": "Mar"
        }
      },
      "Title": "British journal of cancer",
      "ISOAbbreviation": "Br J Cancer"
    },
    "ArticleTitle": "Early cancer diagnosis: reaching targets across whole populations amidst setbacks.",
    "Pagination": {
      "StartPage": "1181",
      "EndPage": "1182",
      "MedlinePgn": "1181-1182"
    },
    "Abstract": {
      "AbstractText": [
        "Early diagnosis of cancer, followed by timely and appropriate therapy, are the cornerstones of the secondary prevention of cancer, thus the NHS has set a 2028 target to achieve 75% early stage (TNM I/II) at cancer diagnosis. In this context,\u00a0Barclay\u00a0et al. evaluated overall, sex, age and deprivation-group-specific progress towards this target based on 202,000 cancer patients diagnosis in 2015. Herein, we discuss their findings which form a\u00a0valuable pre-COVID-19 pandemic status. We discuss the\u00a0impact of the\u00a0pandemic and the efforts being made in innovative early detection and diagnosis\u00a0research."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-7397-3442"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer, Lyon, France. mccormackv@iarc.fr."
          }
        ],
        "LastName": "McCormack",
        "ForeName": "Valerie",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK."
          }
        ],
        "LastName": "Aggarwal",
        "ForeName": "Ajay",
        "Initials": "A"
      }
    ],
    "GrantList": [
      {
        "GrantID": "NIHR300599",
        "Acronym": "DH_",
        "Agency": "Department of Health",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Editorial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Cancer",
    "NlmUniqueID": "0370635",
    "ISSNLinking": "0007-0920"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Age Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "epidemiology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Early Detection of Cancer"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "United Kingdom"
    }
  ],
  "CoiStatement": "The authors declare no competing interests."
}